5/21/2008

The regulatory and financial environment pose key challenges to small biotech firms, panelists said at a conference in North Carolina. Companies can still experience growth by satisfying "the unmet need in disease" and by capitalizing on personalized medicine, Targacept CEO Don deBethizy said.

Related Summaries